Thin-Layer/Isoelectric Focusing (IEF)

Thin-Layer/Isoelectric Focusing (IEF)

Isoelectric focusing is a high-resolution electrophoretic technique used to separate proteins based on their isoelectric points (pI). In pediatrics, it's particularly valuable for hemoglobin analysis and newborn screening.

Key Points

  • Gold standard for hemoglobinopathy diagnosis
  • Superior resolution compared to conventional electrophoresis
  • Can separate hemoglobin variants differing by single amino acid
  • Essential tool in newborn screening programs

Basic Principles

Physical Basis

  • Utilizes pH gradient in electrophoretic medium
  • Proteins migrate until reaching their isoelectric point
  • Separation based on molecular charge differences

Technical Aspects

  • pH gradient created using ampholytes
  • Electric field applied perpendicular to pH gradient
  • Proteins focus into sharp bands
  • Resolution capability of 0.01 pH units

Advantages

  • Higher resolution than conventional methods
  • Can detect subtle hemoglobin variants
  • Requires minimal sample volume
  • Rapid analysis time (2-3 hours)

Methodology

Sample Preparation

  1. Blood collection in EDTA tube
  2. RBC lysis to release hemoglobin
  3. Sample dilution and standardization
  4. Quality control preparation

Procedure Steps

  1. Gel preparation with ampholytes
  2. Sample application
  3. Electric field application
  4. Focusing period (usually 2 hours)
  5. Fixation and staining
  6. Documentation and analysis

Quality Control

  • Internal controls with known hemoglobin variants
  • External quality assessment program participation
  • Regular calibration checks
  • Documentation of lot numbers and expiry dates

Clinical Applications

Primary Applications

  • Newborn screening for hemoglobinopathies
  • Diagnosis of thalassemia syndromes
  • Identification of hemoglobin variants
  • Monitoring therapeutic interventions

Specific Clinical Scenarios

  • Neonatal Screening:
    • Detection of Hb S, C, E, and other variants
    • Early identification of sickle cell disease
    • Beta thalassemia screening
  • Diagnostic Workup:
    • Unexplained anemia
    • Family history of hemoglobinopathy
    • Abnormal CBC findings

Result Interpretation

Normal Pattern

  • HbA: 96-98%
  • HbA2: 2-3%
  • HbF: <1% (after 6 months of age)

Abnormal Patterns

  • Sickle Cell Disease:
    • Presence of HbS band
    • Absence or reduced HbA
    • Variable HbF levels
  • Beta Thalassemia:
    • Elevated HbA2 (>3.5%)
    • Variable HbF elevation
  • HbE Disease:
    • Presence of HbE band
    • Reduced or absent HbA

Important Considerations

  • Age-specific reference ranges
  • Impact of recent transfusion
  • Need for family studies
  • Correlation with clinical findings


Further Reading
Powered by Blogger.